Oncology News & Research | Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Oncology

Lilly receives EU marketing authorisation for abemaciclib in metastatic breast cancer

Lilly receives EU marketing authorisation for abemaciclib in metastatic breast cancer

Oral anticoagulants and cancer-associated thrombosis

CAR T-cell therapy: managing side effects

Implications of licensed standardised chemotherapy doses and their potential impact

Anti-GD2 mAbs for the treatment of high-risk neuroblastoma

The new kid on the block

European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma

European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma

European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia

European Commission approves Vyxeos to treat certain types of high-risk acute myeloid leukaemia

New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA

New patient groups with cancer-associated VTE could be treated with once-daily oral LIXIANA, analysis shows

Why I love being an oncology pharmacist

Why I love being an oncology pharmacist

CHMP gives positive opinion on using tisagenlecleucel to treat two aggressive blood cancers

CHMP gives positive opinion on using tisagenlecleucel to treat two aggressive blood cancers

Drug trial to investigate anti-tumour effect on patients with metastatic breast cancer

Drug trial to investigate anti-tumour effect on patients with metastatic breast cancer